公开查询

医疗器械登记 ANVISA 数据

按编号、产品、持有人企业或 CNPJ 查询。数据来自 ANVISA 开放数据,每日更新。

5,850 记录

产品注册持有人企业类别有效性
DG Gel Rh Pheno80134860143GRIFOLS BRASIL LTDAIV21/09/2035
DG Gel Newborn80134860154GRIFOLS BRASIL LTDAIV28/03/2036
ANTI-SOROS DE FENÓTIPO EXTENDIDO80134860200GRIFOLS BRASIL LTDAIV27/04/2035
DG Gel ABO/Rh(2D)+Kell80134860210GRIFOLS BRASIL LTDAIV10/08/2035
DG Gel ABO/Rh+Kell (RT)80134860211GRIFOLS BRASIL LTDAIV10/08/2035
Extended IV Control80134860213GRIFOLS BRASIL LTDAIV03/11/2035
Essential II Control80134860214GRIFOLS BRASIL LTDAIV03/11/2035
ID CORE XT Reagents80134860219GRIFOLS BRASIL LTDAIV04/07/2036
PROCLEIX ULTRIO ELITE Assay80134860220GRIFOLS BRASIL LTDAIV04/07/2036
Anti-K (Cellano) Mono-Type80134860243GRIFOLS BRASIL LTDAIV10/07/2027
Anti-Fya Mono-Type80134860244GRIFOLS BRASIL LTDAIV10/07/2027
Anti-H Mono-Type80134860245GRIFOLS BRASIL LTDAIV10/07/2027
Anti-D IgG Mono-Type80134860246GRIFOLS BRASIL LTDAIV10/07/2027
Anti-Jka for DG Gel e Anti-Jkb for DG Gel80134860247GRIFOLS BRASIL LTDAIV10/07/2027
Anti-Fya for DG Gel e Anti-Fyb for DG Gel80134860249GRIFOLS BRASIL LTDAIV10/07/2027
Anti-K Mono-Type (2)80134860251GRIFOLS BRASIL LTDAIV26/02/2028
DG Gel ABO/Rh (2D)(RT)80134860259GRIFOLS BRASIL LTDAIV13/12/2028
Família Anti-Kpa Dual e Anti-Kpb Dual80134860261GRIFOLS BRASIL LTDAIV03/06/2029
Procleix Zika Vírus80134860266GRIFOLS BRASIL LTDAIV30/09/2029
Reverse-Cyte 0.8%80134860269GRIFOLS BRASIL LTDAIV25/11/2029
Família Reverse-Cyte® 5%80134860273GRIFOLS BRASIL LTDAIV28/12/2030
Procleix Plasmodium Assay80134860289GRIFOLS BRASIL LTDAIV05/06/2033
Anti-Fyb Mono-Type Dual80134860292GRIFOLS BRASIL LTDAIV26/06/2033
Procleix UltrioPlex E Assay80134860306GRIFOLS BRASIL LTDAIV19/02/2034
ID RHD XT REAGENTES80134860307GRIFOLS BRASIL LTDAIV18/03/2034

来源为 ANVISA 医疗健康产品开放数据。该数据提供注册有效期,并不反映完整登记状态;注册可能在到期前已被注销,而此处未显示。决定购买、进口或销售前,请核对 ANVISA 官方查询门户.

接下来的步骤

您的产品需要在巴西注册

HSC 支持医疗器械 ANVISA 注册,从风险分类到申报进度跟踪。

联系专家